Skip to content

Austin Top 50

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

NRx Pharmaceuticals, Inc.

[object Object]

More Press Releases

September 15, 2026


Digital Marketing Agency Search Influence Named 2026 CityBusiness In the Lead Honoree

September 15, 2026


KCC Expands Workflow Automation and Integration with Release of RiskInsight® Version 4.16

September 15, 2026


Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination

September 15, 2026


Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.